Incidence of Allergic Drug Eruption due to Cotrimoxazole in HIV-Positive Individuals with CD4 ≤200 Cells/ul

Allergic drug eruptions (ADE) remain a challenge in people living with HIV (PLWH), requiring more studies to guide clinical approaches. While cotrimoxazole is widely used as prophylaxis in PLWH, relationship between client characteristics toward the occurrence of cotrimoxazole ADEs is still poorly u...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosali, Irene, Virgayanti, Putu Siska, Marta, Della Sabrina, Danudirgo, Emon Winardi, Hadinata, Sisca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893344/
https://www.ncbi.nlm.nih.gov/pubmed/36700255
http://dx.doi.org/10.1177/23259582221146946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893344/
https://www.ncbi.nlm.nih.gov/pubmed/36700255
http://dx.doi.org/10.1177/23259582221146946

Ejemplares similares